Literature DB >> 22710450

Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.

Sachiko Ono1, Miki Tanioka, Akihiko Fujisawa, Hideaki Tanizaki, Yoshiki Miyachi, Yumi Matsumura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22710450     DOI： 10.1001/archdermatol.2011.2819

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

Review 1.  Management of Cutaneous Angiosarcoma: an Update Review.

Authors:  Siwei Bi; Ai Zhong; Xiya Yin; Jingyi Li; Ying Cen; Junjie Chen
Journal:  Curr Treat Options Oncol       Date:  2022-02-19

2.  Constitutive Activation of mTORC1 in Endothelial Cells Leads to the Development and Progression of Lymphangiosarcoma through VEGF Autocrine Signaling.

Authors:  Shaogang Sun; Song Chen; Fei Liu; Haige Wu; Jonathan McHugh; Ingrid L Bergin; Anita Gupta; Denise Adams; Jun-Lin Guan
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

3.  Radiation therapy for angiosarcoma of the scalp: treatment outcomes of total scalp irradiation with X-rays and electrons.

Authors:  Masaharu Hata; Hidefumi Wada; Ichiro Ogino; Motoko Omura; Izumi Koike; Yoshibumi Tayama; Kazumasa Odagiri; Takeo Kasuya; Tomio Inoue
Journal:  Strahlenther Onkol       Date:  2014-03-13       Impact factor: 3.621

4.  Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.

Authors:  Jieshan Guan; Zhijie Luo; Zhiwei Xiao; Yubin Xie; Lizhu Lin
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430

5.  Successful treatment of angiosarcoma of the scalp with apatinib: a case report.

Authors:  Guanghui Ji; Liu Hong; Ping Yang
Journal:  Onco Targets Ther       Date:  2016-08-11       Impact factor: 4.147
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.